RecruitingNCT05060614
Analyses of Cerebrospinalfluid in Patients With Delirium
MOLECULAR BIOMARKERS IN DELIRIUM AND DEMENTIA
Sponsor
Oslo University Hospital
Enrollment
700 participants
Start Date
Sep 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The current project aims to measure biomarkers in the cerebrospinalfluid (CSF) and serum samples from patients with delirium. We hope to uncover new insights into the pathophysiology of delirium and explore its link to dementia.
Eligibility
Inclusion Criteria1
- Patients with acute hip fracture
Exclusion Criteria2
- Moribund patients.
- Lack of consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREHip fracture surgery
Hip fracture surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05060614
Related Trials
Neurosteer Bedside Monitoring System
NCT067187641 location
Nocturnal Hypoxia in Geriatric Patients After Hip Fracture
NCT040074322 locations
Computer-assisted Cognitive Stimulation Treatment for Delirium
NCT075632441 location
Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
NCT069692871 location
TaVNS for Delirium
NCT072580821 location